Tilray Brands (TLRY) Restructuring Costs (2018 - 2026)
Tilray Brands' (TLRY) quarterly Restructuring Costs came in at $7.2 million in Q2 2026, down 57.78% YoY from $17.0 million in Q2 2025, and up 75.97% on a QoQ basis from $4.1 million in Q1 2026.
Tilray Brands (TLRY) Restructuring Costs (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Restructuring Costs data on file, last reported at $7.2 million in Q2 2026.
- Quarterly Restructuring Costs fell 57.78% year-over-year to $7.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $13.3 million (down 61.35% YoY) and the FY2026 annual result came in at $13.1 million, down 61.75% from the prior year.
- Restructuring Costs climbed to $7.2 million in Q2 2026, from $4.1 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $17.0 million in Q2 2025 to a low of -$19.1 million in Q2 2022.
- A 5-year average of $2.9 million and a median of $4.2 million in 2024 frame the typical range for Restructuring Costs.
- Annual changes were most pronounced in 2023 — Restructuring Costs tumbled 204.12% — and 2024, when it jumped 561.07%.
- Tracing TLRY's Restructuring Costs over 5 years: stood at $8.1 million in 2022, then plunged by 62.28% to $3.0 million in 2023, then surged by 125.81% to $6.9 million in 2024, then tumbled by 85.95% to $965000.0 in 2025, then surged by 645.28% to $7.2 million in 2026.
- The last three Restructuring Costs figures came in at $7.2 million (Q2 2026), $4.1 million (Q1 2026), and $965000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 7.19 Mn |
| Feb 28, 2026 | 4.09 Mn |
| Nov 30, 2025 | 965,000.00 |
| Aug 31, 2025 | 1.01 Mn |
| May 31, 2025 | 17.03 Mn |
| Feb 28, 2025 | 6.13 Mn |
| Nov 30, 2024 | 6.87 Mn |
| Aug 31, 2024 | 4.25 Mn |
| May 31, 2024 | 6.83 Mn |
| Feb 29, 2024 | 5.18 Mn |
| Nov 30, 2023 | 3.04 Mn |
| Aug 31, 2023 | 2.03 Mn |
| May 31, 2023 | -1.48 Mn |
| Feb 28, 2023 | -5.23 Mn |
| Nov 30, 2022 | 8.06 Mn |
| Aug 31, 2022 | 445,000.00 |
| May 31, 2022 | -19.14 Mn |
| Feb 28, 2022 | 5.02 Mn |
| Nov 30, 2021 | 7.04 Mn |
| Aug 31, 2021 | 24.39 Mn |